Celgene Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AGIO | B | Agios Pharmaceuticals, Inc. | 0.00 | |
PTCT | B | PTC Therapeutics, Inc. | 0.00 | |
STRO | C | Sutro Biopharma, Inc. | 0.00 | |
LGND | D | Ligand Pharmaceuticals Incorporated | 0.00 | |
BLUE | F | bluebird bio, Inc. | 0.00 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBP | C | BioShares Biotechnology Products Fund | 8.0 | |
LABD | D | Direxion Daily S&P Biotech Bear 3X Shares | 6.1 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 4.82 | |
PJP | B | PowerShares Dynamic Pharmaceuticals | 3.57 | |
PBE | C | PowerShares Dynamic Biotech & Genome | 3.55 |
Compare ETFs
- Celgene
Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients. Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia due to Low- or Intermediate-1-risk Myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Revlimid is sold through proprietary risk-management distribution programs to ensure safe and appropriate use of these pharmaceuticals. Vidaza is approved for the treatment of patients with MDS.
Celgene Cellular Therapeutics, a subsidiary, is a public cord blood bank.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles